U.S Class(es): 006, 018, 044, 046, 051, 052
Class Status: Active
Name | Cara M. Kearney AstraZeneca Pharmaceuticals LP |
---|---|
Address | 1800 Concord Pike, A2C Wilmington, DE 19850-5437 United States |
Date | Description | Action Tags | Code |
---|---|---|---|
Oct-12-2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM | |
Oct-19-2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Oct-24-2017 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Nov-29-2017 | ASSIGNED TO EXAMINER | DOCKD | |
Nov-30-2017 | NON-FINAL ACTION WRITTEN | CNRTR | |
Dec-01-2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | RFCRE | |
Dec-14-2017 | REFUSAL PROCESSED BY MPU | RFRRP | |
Dec-14-2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | RFCSP | |
Jan-11-2018 | REFUSAL PROCESSED BY IB | RFNTP | |
Feb-12-2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | TROAI | |
Feb-12-2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
Feb-13-2018 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
Feb-13-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Feb-22-2018 | ASSIGNED TO LIE | ALIEA | |
Mar-07-2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Mar-27-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
Mar-27-2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Jun-12-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Sep-12-2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | FICRP | |
Sep-21-2018 | FINAL DISPOSITION PROCESSED | FIMPP | |
Sep-21-2018 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Oct-12-2018 | FINAL DECISION TRANSACTION PROCESSED BY IB | FINOP | |
Jun-12-2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | REM3E | |
Jan-08-2024 | TEAS SECTION 71 & 15 RECEIVED | ES75I | |
Sep-23-2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | APREA | |
Oct-02-2024 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | C75AO | |
Oct-02-2024 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | NA75E |